Page 46 - BH-2-1
P. 46

Brain & Heart                                                                 Practical tips for AD and PD



               decline in Parkinson disease. Nat Rev Neurol, 13: 217–231.   e1898–e1910.
               https://doi.org/10.1038/nrneurol.2017.27           https://doi.org/10.1212/WNL.0000000000005551
            9.   Halliday GM, Leverenz JB, Schneider JS, et al., 2014, The   21.  Giovagnoli AR, Del Pesce M, Mascheroni S,  et al., 1996,
               neurobiological basis of cognitive impairment in Parkinson’s   Trail making test: Normative values from 287 normal adult
               disease. Mov Disord, 29: 634–650.                  controls. Ital J Neurol Sci, 17: 305–309.
               https://doi.org/10.1002/mds.25857                  https://doi.org/10.1007/BF01997792
            10.  Jellinger KA, 2009, Formation and development of Lewy   22.  Sarazin  M,  Berr  C,  De  Rotrou  J,  et al.,  2007,  Amnestic
               pathology: A critical update. J Neurol, 256: 270–279.   syndrome of the medial temporal type identifies prodromal
                                                                  AD: A longitudinal study. Neurology, 69: 1859–1867.
               https://doi.org/10.1007/s00415-009-5243-y
                                                                  https://doi.org/10.1212/01.wnl.0000279336.36610.f7
            11.  Weintraub D, Mamikonyan E, 2019, The neuropsychiatry of
               Parkinson disease: A perfect storm. Am J Geriatr Psychiatry,   23.  Nussbaum S, May N, Cutler L,  et al., 2022, Failing
               27: 998–1018.                                      performance  validity  cutoffs  on  the  Boston  naming  test
                                                                  (BNT) is specific, but insensitive to non-credible responding.
               https://doi.org/10.1016/j.jagp.2019.03.002
                                                                  Dev Neuropsychol, 47: 17–31.
            12.  Marder K, Tang MX, Cote L, et al., 1995, The frequency      https://doi.org/10.1080/87565641.2022.2038602
               and  associated  risk  factors  for  dementia in  patients  with
               Parkinson’s disease. Arch Neurol, 52: 695–701.   24.  Shulman KI, 2000, Clock-drawing: Is it the ideal cognitive
                                                                  screening test? Int J Geriatr Psychiatry, 15: 548–561.
               https://doi.org/10.1001/archneur.1995.00540310069018
                                                                  https://doi.org/10.1002/1099-1166(200006)15:6<548:aid-
            13.  Hu X, Meiberth D, Newport B,  et al., 2015, Anatomical   gps242>3.0.co;2-u
               correlates of the neuropsychiatric symptoms in Alzheimer’s
               disease. Curr Alzheimer Res, 12: 266–277.       25.  Reisberg B, Ferris SH, de Leon MJ, et al., 1982, The Global
                                                                  Deterioration Scale for assessment of primary degenerative
               https://doi.org/10.2174/1567205012666150302154914
                                                                  dementia. Am J Psychiatry, 139: 1136–1139.
            14.  Aludin S, Schmill LP, 2021, MRI signs of Parkinson’s disease
               and atypical parkinsonism. Rofo, 193: 1403–1410.      https://doi.org/10.1176/ajp.139.9.1136
                                                               26.  Berg L, 1988, Clinical dementia rating (CDR).
               https://doi.org/10.1055/a-1460-8795
                                                                  Psychopharmacol Bull, 24: 637–639.
            15.  Leverenz JB, Quinn JF, Zabetian C, et al., 2009, Cognitive
               impairment and dementia in patients with Parkinson   27.  Blessed G, Tomlinson BE, Roth M, 1968, The association
               disease. Curr Top Med Chem, 9: 903–912.            between quantitative measures of dementia and of senile
                                                                  change in the cerebral grey matter of elderly subjects. Br J
               https://doi.org/10.2174/156802609789378218         Psychiatry, 114: 797–811.
            16.  Jack CR Jr., Bennett DA, Blennow K, et al., 2018, NIA-AA      https://doi.org/10.1192/bjp.114.512.797
               research framework: Toward a biological definition of
               Alzheimer’s disease. Alzheimers Dement, 14: 535–562.   28.  Goetz CG, Fahn S, Martinez-Martin P,  et al., 2007,
                                                                  Movement disorder society-sponsored revision of the
               https://doi.org/10.1016/j.jalz.2018.02.018         unified Parkinson’s disease rating scale (MDS-UPDRS):
            17.  Postuma RB, Berg D, Stern M,  et al., 2015, MDS clinical   Process, format, and clinimetric testing plan. Mov Disord,
               diagnostic criteria for Parkinson’s disease.  Mov Disord,   22: 41–47.
               30: 1591–1601.                                     https://doi.org/10.1002/mds.21198
               https://doi.org/10.1002/mds.26424               29.  Royall DR, Cordes JA, Polk M, 1998, CLOX: An executive
                                                                  clock  drawing  task.  J  Neurol Neurosurg Psychiatry, 64: 
            18.  Güngen, C,  Ertan, T,  Eker E,  et al., 2002,  Reliability and
               validity of the standardized Mini Mental State Examination   588–594.
               in the diagnosis of mild dementia in Turkish population.      https://doi.org/10.1136/jnnp.64.5.588
               Turk Psikiyatri Derg, 13: 273–281.
                                                               30.  Lee JH, Oh ES, Jeong SH, et al., 2011, Longitudinal changes
            19.  Conway AR, Kane MJ, Engle RW, 2003, Working memory   in clock drawing test (CDT) performance according to
               capacity and its relation to general intelligence. Trends Cogn   dementia subtypes and severity. Arch Gerontol Geriatr, 53:
               Sci, 7: 547–552.                                   e179–e182.
               https://doi.org/10.1016/j.tics.2003.10.005         https://doi.org/10.1016/j.archger.2010.08.010
            20.  Lawrence AJ, Zeestraten EA, Benjamin P,  et al., 2018,   31.  Henry  JD,  Crawford  JR, 2004, Verbal fluency  deficits  in
               Longitudinal decline in structural networks predicts   Parkinson’s disease: A meta-analysis. J Int Neuropsychol Soc,
               dementia in cerebral small vessel disease.  Neurology, 90:   10: 608–622.


            Volume 2 Issue 1 (2024)                         10                        https://doi.org/10.36922/bh.1712
   41   42   43   44   45   46   47   48   49   50   51